Clinical Trial Update: Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot clinical trial evaluated the safety and potential efficacy of Anakinra (interleukin-1 receptor antagonist) in patients with heart failure. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-05-16